- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
ARNA Market Currents
more »
-
Tuesday 10:09 AM Arena Pharmaceuticals (ARNA) +4.7% to $6.24 after it yesterday completed its secondary public offering and underwriters fully exercised their option to purchase additional stock. Arena sold almost 12.65M shares at $5.50 each, raising nearly $70M.
Comment![Healthcare, On the Move]
ARNA in Focus
more »
ARNA Related Articles
more »
ARNA News
more »
-
at MarketWatch.com (Tue, 6:40AM)
-
at CNBC.com (May 16, 2012)
-
at CNBC.com (May 16, 2012)
-
at CNBC.com (May 15, 2012)
-
at MarketWatch.com (May 15, 2012)
ARNA Press Releases and Filings
more »
-
PR Newswire (Mon, 4:01PM)
-
PR Newswire (May 16, 2012)
-
PR Newswire (May 15, 2012)
-
PR Newswire (May 10, 2012)
-
PR Newswire (May 10, 2012)
ARNA Latest Transcript
more »
-
Tue, Nov 10, 2009Popular searches: apd597, compared, time, approximately, robert, 2009, pharmaceutical, fda, aria, blossom.
ARNA Cramer
more »
ARNA Instablog posts
more »
ARNA vs. ETF Alternatives
Company Description
We are a clinical-stage biopharmaceutical company committed to discovering and developing innovative therapies offering significant medical advances and new options for patients. We are focused on discovering, developing and commercializing oral drugs in four major therapeutic areas:... More
